Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients.
The euglobulin clot lysis time (ECLT), a traditional measure of plasminogen activation, directly depends on plasma fibrinogen (FBG) level. This fact was neglected in studies concluding that prolonged ECLT in chronic hemodialysis (HD) patients pointed exclusively to impaired fibrinolysis. We studied the relations between ECLT and plasma FBG levels in HD patients in relation to certain hepatic and inflammatory markers. Median ECLT of 320 minutes (range, 150 to 620 minutes) and plasma FBG of 306 mg/dL (range, 171 to 553 mg/dL) were higher in 75 HD patients than in 60 healthy controls (Mann-Whitney p < 0.0001). There were positive associations between these parameters both in the patients (Spearman p = 0.273, p = 0.018) and the controls (p = 0.672, p < 0.0001). The FBG-corrected ECLT (plasma FBG/ECLT) (in mg/[min x dL]) in the patients (0.92 [range, 0.47 to 2.43]) was not different (p = 0.065) from that in the controls (1.08 [0.58 to 1.67]). In the patients, serum alanine aminotransferase inversely correlated with ECLT (p = -0.306, p = 0.008) and FBG (p = -0.310, p = 0.007), whereas serum C-reactive protein was associated positively with these variables (p = 0.383, p = 0.0007; p = 0.477, p < 0.0001, respectively). The FBG-corrected ECLT was not related to either marker. In conclusion, increased plasma FBG level, a continuum between liver dysfunction and stimulation by chronic inflammation, is an important determinant of prolonged ECLT in HD patients. The FBG-corrected ECLT value suggests that baseline activation of fibrinolysis is normal in these patients, and that this simple index could be useful in its laboratory assessment.
Borawski
J
J
Department of Nephrology and Internal Medicine, Medical Academy, Białystok, Poland. jborawsk@polbox.com
Myśliwiec
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood / Q000502:physiology; D001780:Blood Coagulation Tests / Q000592:standards; D002097:C-Reactive Protein / Q000032:analysis / Q000502:physiology; D016022:Case-Control Studies; D003951:Diagnostic Errors; D005260:Female; D005340:Fibrinogen / Q000032:analysis* / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000097:blood; D008107:Liver Diseases / Q000097:blood; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012712:Serum Globulins / Q000494:pharmacology*; D013997:Time Factors
D012712:Serum Globulins; D005340:Fibrinogen; D002097:C-Reactive Protein; D000410:Alanine Transaminase